41.45
Schlusskurs vom Vortag:
$41.07
Offen:
$41.08
24-Stunden-Volumen:
2.20M
Relative Volume:
0.46
Marktkapitalisierung:
$33.67B
Einnahmen:
$28.43B
Nettoeinkommen (Verlust:
$1.16B
KGV:
28.67
EPS:
1.4457
Netto-Cashflow:
$1.26B
1W Leistung:
-5.41%
1M Leistung:
-6.94%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Medline Inc Stock (MDLN) Company Profile
Firmenname
Medline Inc
Sektor
Telefon
847-949-3000
Adresse
3 LAKES DRIVE, NORTHFIELD
Compare MDLN vs ISRG, BDX, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MDLN
Medline Inc
|
41.48 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ISRG
Intuitive Surgical Inc
|
471.14 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.56 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
76.99 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
231.00 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-05 | Eingeleitet | Tigress Financial | Buy |
| 2026-01-21 | Bestätigt | BTIG Research | Buy |
| 2026-01-12 | Eingeleitet | Citigroup | Buy |
| 2026-01-12 | Eingeleitet | Deutsche Bank | Hold |
| 2026-01-12 | Eingeleitet | Evercore ISI | Outperform |
| 2026-01-12 | Eingeleitet | Goldman | Buy |
| 2026-01-12 | Eingeleitet | JP Morgan | Overweight |
| 2026-01-12 | Eingeleitet | Jefferies | Buy |
| 2026-01-12 | Eingeleitet | Leerink Partners | Outperform |
| 2026-01-12 | Eingeleitet | Mizuho | Outperform |
| 2026-01-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2026-01-12 | Eingeleitet | Piper Sandler | Overweight |
| 2026-01-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2026-01-12 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2026-01-12 | Eingeleitet | Stifel | Buy |
| 2026-01-12 | Eingeleitet | TD Cowen | Buy |
| 2026-01-12 | Eingeleitet | Truist | Buy |
| 2026-01-12 | Eingeleitet | UBS | Buy |
| 2026-01-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2026-01-12 | Eingeleitet | William Blair | Outperform |
| 2026-01-12 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Medline Inc Aktie (MDLN) Neueste Nachrichten
Medline Inc (MDLN) Stock Price Down 3.6% on Mar 12 - GuruFocus
Medline builds up in Texas, its first post-IPO expansion - Crain's Chicago Business
Medline Announces Construction of 1.2 Million Sq. Ft Distribution Center in Midlothian Texas - marketscreener.com
Medline breaks ground on Texas distribution center - Investing.com
Medline’s Mega Midlothian Hub Aims To Dominate South Dallas Supply Chain - Hoodline
Medline closes secondary offering of Class A common stock - Medical Buyer
Medline's growth continues as it breaks ground on 1.2 million sq. ft distribution center in Midlothian, Texas - Financial Times
Here Are Wednesday’s Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More - 24/7 Wall St.
Medline stockholders sell 86.3 million shares at $41 each - Investing.com India
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares - The Manila Times
Medline Inc. announces closing of secondary offering of - GlobeNewswire
Medline highlights top-performing distribution centers - HME News
Medline stockholders sell 86.3 million shares at $41 each By Investing.com - Investing.com Nigeria
Medline (MDLN) Q4 Net Sales Rise 14.8% to $7.8B Following Completion of IPO - Bitget
Medline (MDLN) Q4 net sales rise 14.8% to $7.8B following completion of IPO - MSN
Medline Awards Distribution Center of the Year and SAFE Awards - Finviz
Medline stock price target raised to $60 by Tigress Financial - Investing.com South Africa
Medline prices $3B secondary offering at $41 per share - MSN
Medline stock price target reaffirmed at $55 by BTIG - Investing.com
Medline: $3.1 Billion Share Sale By Private Equity Backers - Pulse 2.0
Medline (MDLN) CCO discloses Class A, B shares and incentive unit grants - Stock Titan
Medline Inc. announces pricing of secondary offering of class A common stock - Sahm
Medline’s buyout firm backers raise $3.1B in share sale - Crain's Chicago Business
Medline’s PE owners cash out US$3.1bn in early lockup release - ifre.com
Medline Secondary Common Stock Offering Prices; Shares Down Pre-Bell - marketscreener.com
Medline stockholders price secondary offering at $41 per share By Investing.com - Investing.com Nigeria
Medline stockholders price secondary offering at $41 per share - Investing.com
Medline’s Buyout Firm Backers Raise $3.1 Billion in Share Sale - Bloomberg.com
Medline Inc. Announces Pricing Of Secondary Offering Of Class A Common Stock - TradingView
Shareholders of the American Medline intend to sell shares worth $ 3.4 billion - AKM.RU
Ear Syringe Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Medline Backers Launch $3.4B Secondary Sale Near Chicago - Hoodline
Blackstone, Carlyle, Hellman & Friedman Offer 75M Shares For MedlineMedline (NASDAQ:MDLN) - Benzinga
Medline’s PE backers start stake sale worth $3.4 billion - Crain's Chicago Business
Medline Shareholders Seek $3.4 Billion Stake Sale - Transport Topics
Medline’s PE Backers Start Stake Sale Worth $3.4 Billion - Bloomberg.com
Medline stockholders launch 75 million share offering - Investing.com
Medline shares fall 4.4% as major investors launch secondary offering By Investing.com - Investing.com Nigeria
Medline stockholders launch 75 million share offering By Investing.com - Investing.com Canada
Medline announces $3.6B secondary offering from private equity firms - MassDevice
Medline Inc. announces launch of secondary offering of Class A common stock - GlobeNewswire
Form S-1 Medline Inc. - StreetInsider
USA Herald - USA Herald
The 20+ Club: Ron Woosley - Medline Newsroom
Medline expands AI platform and warehouse robotics - Digital Commerce 360
Medline Inc.: Fundamental Analysis and Financial Ratings | MDLN | US58507V1070 - marketscreener.com
The Analyst Verdict: Medline In The Eyes Of 29 Experts - Benzinga
Wells Fargo & Company Increases Medline (NASDAQ:MDLN) Price Target to $47.00 - MarketBeat
Finanzdaten der Medline Inc-Aktie (MDLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Medline Inc-Aktie (MDLN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Carlyle Group Inc. | 10% Owner |
Mar 10 '26 |
Sale |
41.00 |
26,105,840 |
1,070,339,440 |
127,567,724 |
| Carlyle Mozart Coinvestment Ho | 10% Owner |
Mar 10 '26 |
Sale |
41.00 |
26,105,840 |
1,070,339,440 |
127,567,724 |
| CP Circle ML Holdco GP, LLC | 10% Owner |
Mar 10 '26 |
Sale |
41.00 |
26,105,840 |
1,070,339,440 |
127,567,724 |
| TC Group Cayman Investment Hol | 10% Owner |
Mar 10 '26 |
Sale |
41.00 |
26,105,840 |
1,070,339,440 |
127,567,724 |
| BCP 8 Holdings Mozart Manager | 10% Owner |
Mar 10 '26 |
Sale |
40.51 |
27,852,986 |
1,128,268,757 |
1,539 |
| BX Mozart ML-2 Holdco L.P. | 10% Owner |
Mar 10 '26 |
Sale |
40.51 |
27,852,986 |
1,128,268,757 |
1,539 |
| Hellman & Friedman Capital Par | 10% Owner |
Dec 18 '25 |
Sale |
28.37 |
6,088,371 |
172,716,735 |
4,806,160 |
| GIC Private Ltd | 10% Owner |
Dec 18 '25 |
Buy |
29.00 |
12,586,206 |
364,999,974 |
27,241,378 |
| GIC Private Ltd | 10% Owner |
Dec 18 '25 |
Sale |
28.37 |
10,204,351 |
289,480,090 |
91,555,447 |
| TC Group VII S1, L.L.C. | 10% Owner |
Dec 18 '25 |
Sale |
29.00 |
19,136,333 |
554,953,657 |
145,924,924 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):